Papadaki V, Erpapazoglou Z, Kokkori M, Rogalska M, Potiri M, Birladeanu A
NAR Cancer. 2023; 5(3):zcad046.
PMID: 37636315
PMC: 10448856.
DOI: 10.1093/narcan/zcad046.
Malki I, Liepina I, Kogelnik N, Watmuff H, Robinson S, Lightfoot A
Nucleic Acids Res. 2022; 50(22):13045-13062.
PMID: 36537190
PMC: 9825155.
DOI: 10.1093/nar/gkac1181.
Isaac R, Vinik Y, Mikl M, Nadav-Eliyahu S, Shatz-Azoulay H, Yaakobi A
iScience. 2022; 25(11):105270.
PMID: 36304109
PMC: 9593240.
DOI: 10.1016/j.isci.2022.105270.
Ferragut Cardoso A, Banerjee M, Al-Eryani L, Sayed M, Wilkey D, Merchant M
Environ Health Perspect. 2022; 130(1):17011.
PMID: 35072517
PMC: 8785870.
DOI: 10.1289/EHP9676.
Blake D, Lynch K
Immunol Rev. 2021; 304(1):30-50.
PMID: 34368964
PMC: 8616797.
DOI: 10.1111/imr.13018.
Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?.
Marcelo A, Koppenol R, de Almeida L, Matos C, Nobrega C
Cell Death Dis. 2021; 12(6):592.
PMID: 34103467
PMC: 8187637.
DOI: 10.1038/s41419-021-03873-8.
Depleting deubiquitinating enzymes promotes apoptosis in glioma cell line via RNA binding proteins SF2/ASF1.
Vashistha V, Bhardwaj S, Yadav B, Yadav A
Biochem Biophys Rep. 2020; 24:100846.
PMID: 33319070
PMC: 7726668.
DOI: 10.1016/j.bbrep.2020.100846.
Alternative splicing and cancer: insights, opportunities, and challenges from an expanding view of the transcriptome.
Cherry S, Lynch K
Genes Dev. 2020; 34(15-16):1005-1016.
PMID: 32747477
PMC: 7397854.
DOI: 10.1101/gad.338962.120.
Nutrigenomics: Opportunities & challenges for public health nutrition.
Reddy V, Palika R, Ismail A, Pullakhandam R, Reddy G
Indian J Med Res. 2019; 148(5):632-641.
PMID: 30666988
PMC: 6366269.
DOI: 10.4103/ijmr.IJMR_1738_18.
Characterization of cis-acting elements that control oscillating alternative splicing.
Goldammer G, Neumann A, Strauch M, Muller-McNicoll M, Heyd F, Preussner M
RNA Biol. 2018; 15(8):1081-1092.
PMID: 30200840
PMC: 6161694.
DOI: 10.1080/15476286.2018.1502587.
Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.
Berasain C, Elizalde M, Urtasun R, Castillo J, Garcia-Irigoyen O, Uriarte I
Hepat Oncol. 2018; 1(2):241-252.
PMID: 30190958
PMC: 6095334.
DOI: 10.2217/hep.13.17.
Glycogen synthase kinase-3 and alternative splicing.
Liu X, Klein P
Wiley Interdiscip Rev RNA. 2018; 9(6):e1501.
PMID: 30118183
PMC: 6185797.
DOI: 10.1002/wrna.1501.
Insulin regulates titin pre-mRNA splicing through the PI3K-Akt-mTOR kinase axis in a RBM20-dependent manner.
Zhu C, Yin Z, Tan B, Guo W
Biochim Biophys Acta Mol Basis Dis. 2017; 1863(9):2363-2371.
PMID: 28676430
PMC: 5547897.
DOI: 10.1016/j.bbadis.2017.06.023.
Sec16 alternative splicing dynamically controls COPII transport efficiency.
Wilhelmi I, Kanski R, Neumann A, Herdt O, Hoff F, Jacob R
Nat Commun. 2016; 7:12347.
PMID: 27492621
PMC: 4980449.
DOI: 10.1038/ncomms12347.
Negative autoregulation of BMP dependent transcription by SIN3B splicing reveals a role for RBM39.
Faherty N, Benson M, Sharma E, Lee A, Howarth A, Lockstone H
Sci Rep. 2016; 6:28210.
PMID: 27324164
PMC: 4914931.
DOI: 10.1038/srep28210.
Post-transcriptional control of the mammalian circadian clock: implications for health and disease.
Preussner M, Heyd F
Pflugers Arch. 2016; 468(6):983-91.
PMID: 27108448
PMC: 4893061.
DOI: 10.1007/s00424-016-1820-y.
Alternative splicing within the Wnt signaling pathway: role in cancer development.
Sumithra B, Saxena U, Das A
Cell Oncol (Dordr). 2016; 39(1):1-13.
PMID: 26762488
DOI: 10.1007/s13402-015-0266-0.
The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.
Daguenet E, Dujardin G, Valcarcel J
EMBO Rep. 2015; 16(12):1640-55.
PMID: 26566663
PMC: 4693517.
DOI: 10.15252/embr.201541116.
Global analysis of physical and functional RNA targets of hnRNP L reveals distinct sequence and epigenetic features of repressed and enhanced exons.
Cole B, Tapescu I, Allon S, Mallory M, Qiu J, Lake R
RNA. 2015; 21(12):2053-66.
PMID: 26437669
PMC: 4647460.
DOI: 10.1261/rna.052969.115.
Splicing Regulation: A Molecular Device to Enhance Cancer Cell Adaptation.
Pagliarini V, Naro C, Sette C
Biomed Res Int. 2015; 2015:543067.
PMID: 26273627
PMC: 4529921.
DOI: 10.1155/2015/543067.